UNSPSC 51474004: Chlorhexidine/chlorocresol/hexamidine

This classification is for a combination antiseptic solution. The first component, CHLORHEXIDINE, has US FDA Unique Ingredient Identifier of R4KO0DY52L. The second component, CHLOROCRESOL, has US FDA Unique Ingredient Identifier of 36W53O7109.The third component, HEXAMIDINE, has US FDA Unique Ingredient Identifier of 3483C2H13H.

UNSPSC 51474004 Chlorhexidine/chlorocresol/hexamidine is a Commodity code with minimal recent state and local procurement activity tied directly to its nominal scope. The recent opportunities block contains no solicitations for these specific antimicrobial agents; instead, it lists unrelated procurements (networking events, vendor forums, engineering services, pharmacy benefits administration, medical oxygen rental, and multi-source pharmaceutical contracting through a cooperative). The Seminole County IFB for Naloxone and Drug Deactivation Systems and the City of Tucson RFP for BLS/ALS pharmaceuticals and supplies represent the closest analog activities—both involve emergency medical consumables distributed through county and municipal health systems—but neither explicitly names chlorhexidine, chlorocresol, or hexamidine products. The Pinellas County forensic drug standards procurement (ITQ 26-0305-ITQ) solicits certified reference materials for toxicology and seized-drug analysis, which is analytically unrelated to antimicrobial agents used in clinical or disinfection settings.

The source does not support recent state or local solicitations for chlorhexidine-based disinfectants, oral rinses, wound irrigation products, or other formulations under this code. Procurement activity in related pharmaceutical and medical supply categories appears concentrated in Florida (Seminole County, Pinellas County, Collier County) and Arizona (Tucson), with cooperative purchasing vehicles and federal funding mechanisms (FEMA, Paul Coverdell forensic improvement grants, ARPA/HUD/FTA) supporting some opportunities. Without concrete examples of state and local governments buying chlorhexidine or its chemical analogs under this code in the past six months, characterizing issuing-body patterns, geographic concentration, or representative bid cycles is not supported by the source material.